We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.07%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.05B
AUM Growth
+$503M
(+14%)
Cap. Flow
+$330M
Cap. Flow
% of AUM
8.14%
Top 10 Holdings %
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155
Avg Time Held Equity + Options
4.2
quarters
Top 10 Avg Time Held Equity + Options
1.2
quarters
Top 20 Avg Time Held Equity + Options
1.3
quarters
Avg Time Held Equity only
4.5
quarters
Top 10 Avg Time Held Equity only
1.2
quarters
Top 20 Avg Time Held Equity only
1.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$269M |
| 2 |
Stericycle Inc
SRCL
|
+$141M |
| 3 |
Marathon Oil Corporation
MRO
|
+$108M |
| 4 |
ChampionX
CHX
|
+$103M |
| 5 |
Spirit AeroSystems
SPR
|
+$95.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equitrans Midstream Corporation Common Stock
ETRN
|
+$149M |
| 2 |
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$81.8M |
| 3 |
Southwestern Energy Company
SWN
|
+$56.7M |
| 4 |
Union Pacific
UNP
|
+$24.2M |
| 5 |
US Steel
X
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 20.91% |
| 2 | Technology | 19.62% |
| 3 | Healthcare | 14.36% |
| 4 | Industrials | 11.13% |
| 5 | Consumer Staples | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
501
CALL
AstraZeneca
AZN
$247B
| – | – |
-7,500
| Closed | -$10.3K | – |
|
502
CALL
Baxter International
BAX
$12.6B
| – | – |
-90,000
| Closed | -$18K | – |
|
503
CALL
BridgeBio Pharma
BBIO
$12.8B
| – | – |
-35,000
| Closed | -$4.38K | – |
|
504
CALL
Beam Therapeutics
BEAM
$2.65B
| – | – |
-30,000
| Closed | -$12K | – |
|
505
Box
BOX
$4.99B
| – | – |
-150,000
| Closed | -$3.97M | – |
|
506
PUT
DELISTED
Blueprint Medicines
BPMC
| – | – |
-20,000
| Closed | -$51K | – |
|
507
B2Gold
BTG
$6.94B
| – | – |
-334,874
| Closed | -$904K | – |
|
508
CarGurus
CARG
$2.57B
| – | – |
-65,000
| Closed | -$1.7M | – |
|
509
Carrier Global
CARR
$45.8B
| – | – |
-61,600
| Closed | -$3.89M | – |
|
510
Cadence Design Systems
CDNS
$97.2B
| – | – |
-38,000
| Closed | -$11.7M | – |
|
511
Coherent
COHR
$61.6B
| – | – |
-20,000
| Closed | -$1.45M | – |
|
512
ConocoPhillips
COP
$161B
| – | – |
-42,316
| Closed | -$4.84M | – |
|
513
Canadian Pacific Kansas City
CP
$74.2B
| – | – |
-83,000
| Closed | -$6.53M | – |
|
514
California Resources
CRC
$4.7B
| – | – |
-14,046
| Closed | -$748K | – |
|
515
Cardiff Oncology
CRDF
$84M
| – | – |
-150,000
| Closed | -$333K | – |
|
516
CRH
CRH
$54.2B
| – | – |
-177,000
| Closed | -$13.3M | – |
|
517
PUT
CRISPR Therapeutics
CRSP
$5.16B
| – | – |
-15,000
| Closed | -$25.5K | – |
|
518
CALL
Community Health Systems
CYH
$389M
| – | – |
-525,000
| Closed | -$88.1K | – |
|
519
CALL
Cytokinetics
CYTK
$8.75B
| – | – |
-23,000
| Closed | -$17.8K | – |
|
520
DoorDash
DASH
$85.1B
| – | – |
-52,500
| Closed | -$5.71M | – |
|
521
Dell
DELL
$373B
| – | – |
-29,576
| Closed | -$4.08M | – |
|
522
PUT
Danaher
DHR
$155B
| – | – |
-10,000
| Closed | -$54.5K | – |
|
523
DocuSign
DOCU
$13.3B
| – | – |
-35,000
| Closed | -$1.87M | – |
|
524
Dover
DOV
$25.4B
| – | – |
-97,700
| Closed | -$17.6M | – |
|
525
PUT
DexCom
DXCM
$31.7B
| – | – |
-15,000
| Closed | -$25.9K | – |
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q3 2024 Portfolio in Review
As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
UBS O'Connor deployed $330M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.
By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.
- UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
- UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
- UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
- UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
- UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
- UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
- UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.
Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.